VC-backed Searchlight Pharma to buy Norgine's Canadian assets
Searchlight Pharma Inc has agreed to acquire the Canadian assets of Merus Labs International Inc, an affiliate of European pharmaceutical company Norgine BV. Terms weren't disclosed. As a result, Searchlight, a Montréal-based specialty pharmaceutical company, will own and assume the distribution and promotion of Merus prescription drugs Enablex and Vancocin in Canada. Norgine will retain all assets outside of Canada. Last year, Searchlight raised financing from Emerillon Capital and Fonds de solidarité FTQ to back its growth and therapeutic area expansion.
1 October 2018•4 mins read
